A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4+ T cell vaccine efficiently enhances anti-leukemia immunityJiaqi Li(Xi'an Jiaotong University), Siguo Hao(XinHua Hospital)Frontiers in ImmunologyNovember 16, 202210.3389/fimmu.2022.1043484Cited by 12SaveCiteExport RISWatch citationsRelated PapersPre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study|Journal of Hematology & Oncology|2020|82Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules|Cellular Oncology|2020|33